Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoven versus Vaminolact in infants after gastrointestinal surgery
2008-000429-20Phase 2Completed
- Sponsor
- Fresenius Kabi
- Start
- Jul 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intestinal failure (IF) comparing Neoven arm with Vaminolact arm (2 arms). Primary endpoint: Profile of all amino acids in plasma. Started Jul 2008; status: completed.
02
Drugs
NeovenVaminolact
03
Conditions
intestinal failure (IF)
Beyond the preview
Go deeper on 2008-000429-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000429-20.